Loading
Latest filing published 14 Dec 2022 for ZyVersa Therapeutics, Inc.. Read the official filing
No signal scores available.
One trade, one date: on 14 December 2022, Nicholas A. LaBella Jr. disclosed a share grant in ZyVersa Therapeutics, Inc. No broader history exists yet. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration